Page last updated: 2024-09-02

ecopipam and Smoking Cessation

ecopipam has been researched along with Smoking Cessation in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bigelow, GE; Donny, EC; Nann-Vernotica, E; Walsh, SL	1

Trials

1 trial(s) available for ecopipam and Smoking Cessation

Article	Year
Repeated administration of the D1/5 antagonist ecopipam fails to attenuate the subjective effects of cocaine. Psychopharmacology, 2001, Volume: 155, Issue:4 Topics: Adult; Benzazepines; Cocaine; Cocaine-Related Disorders; Cross-Over Studies; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hemodynamics; Humans; Injections, Intravenous; Male; Receptors, Dopamine D1; Receptors, Dopamine D5; Smoking; Smoking Cessation; Surveys and Questionnaires	2001

Article

Year

Repeated administration of the D1/5 antagonist ecopipam fails to attenuate the subjective effects of cocaine.

Psychopharmacology, 2001, Volume: 155, Issue:4

Topics: Adult; Benzazepines; Cocaine; Cocaine-Related Disorders; Cross-Over Studies; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hemodynamics; Humans; Injections, Intravenous; Male; Receptors, Dopamine D1; Receptors, Dopamine D5; Smoking; Smoking Cessation; Surveys and Questionnaires

2001